Name: MERCK & CO. INC. (MRK) Stock
Brand: MERCK & CO. INC.
Rating: 7.5 (3 reviews)

MRK Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Chartmill - Mentions: DVN APP CI ALGN ...

Exploring the top movers within the S&P500 index during today's session.

5 days ago - By: Chartmill - Mentions: DVN APP NKE ALGN ...

What's going on in today's session: S&P500 movers

14 hours ago - By: The Motley Fool - Mentions: SCHD KO CVX COP ...

These 2 Dividend ETFs Are a Retiree's Best Friend

2 days ago - By: Investor's Business Daily - Mentions: RY RY.CA CDTX

Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal

2 days ago - By: Zacks Investment Research

Here's Why Merck (MRK) is a Strong Growth Stock

2 days ago - By: Benzinga - Mentions: CDTX MRNA

Merck Makes Big Bet On Flu Protection With Cidara Buyout

2 days ago - By: Zacks Investment Research - Mentions: BMY JNJ PFE LLY ...

Pharma ETFs in Spotlight Following Robust Q3 Earnings Results

2 days ago - By: Bloomberg - Mentions: CDTX

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal

2 days ago - By: Stocktwits - Mentions: CDTX

Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio

2 days ago - By: Merck & Co., Inc.

Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent

3 days ago - By: Stocktwits - Mentions: CDTX VRNA PFE NVO ...

Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium

3 days ago - By: Zacks Investment Research - Mentions: BRK AMAT AU BZH ...

Pulling Back for a Fresh Look at This Recent Pullback

3 days ago - By: Zacks Investment Research - Mentions: BMY PFE

BMY's Growth Portfolio Shines in Q3: Turning Point Ahead?

3 days ago - By: Merck & Co., Inc.

Merck to Participate in the Jefferies Global Healthcare Conference in London

4 days ago - By: The Motley Fool - Mentions: PFE MTSR

Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?

4 days ago - By: Zacks Investment Research - Mentions: DVN ADP

Stock Market News for Nov 12, 2025

5 days ago - By: Benzinga - Mentions: AMZN GOOG MSFT STM ...

Google To Run Ohio Data Centers On Solar Power From TotalEnergies

6 days ago - By: Zacks Investment Research - Mentions: MRNA SMMT

Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3?

6 days ago - By: Zacks Investment Research - Mentions: BMY PFE

Bristol Myers Gains 7.2% in a Month: Buy, Sell or Hold the Stock?

7 days ago - By: Merck & Co., Inc.

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial

8 days ago - By: Investor's Business Daily - Mentions: REGN AMGN SNY

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%

8 days ago - By: Merck & Co., Inc.

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial

9 days ago - By: Zacks Investment Research

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock

10 days ago - By: Zacks Investment Research - Mentions: GSK PFE MRNA

Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans

10 days ago - By: Zacks Investment Research - Mentions: AZN PFE

AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform

10 days ago - By: Chartmill

Merck & Co. Inc. (NYSE:MRK) Presents a Compelling Case for Dividend Investors

12 days ago - By: Stocktwits - Mentions: DUHP DWSH

Merck Stock Rises Upon Receipt Of $700M In Funding For Experimental Cancer Drug

17 days ago - By: Chartmill

MERCK & CO. INC. (MRK) Stock News